Literature DB >> 7771104

P450 in the rat and man: methods of investigation, substrate specificities and relevance to cancer.

V Nedelcheva1, I Gut.   

Abstract

1. Considerable evidence has been accumulated that orthologous rat and human P450 forms oxidize numerous chemicals in a highly similar manner, including the detoxication and activation of mutagens and carcinogens. 2. Nevertheless, certain specific substrates of rat P450s are not so well oxidized by the orthologous human forms, and vice versa. 3. Certain mutagens and carcinogens can be activated in a similar way by different (non-orthologous) forms in rat and man, confirming that studies on animals, directed ultimately to man, can be indicative but not predicative of chemical mutagenesis and carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7771104     DOI: 10.3109/00498259409038673

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  24 in total

1.  Effect of methamphetamine on the pharmacokinetics of dextromethorphan and midazolam in rats.

Authors:  M Dostalek; E Hadasova; M Hanesova; J Pistovcakova; A Sulcova; J Jurica; J Tomandl; I Linhart
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2005 Jul-Sep       Impact factor: 2.441

2.  Selective downregulation of hepatic cytochrome P450 expression and activity in a rat model of inflammatory pain.

Authors:  Denis Projean; Sophie Dautrey; Huy Khan Vu; Thierry Groblewski; Jean-Louis Brazier; Julie Ducharme
Journal:  Pharm Res       Date:  2005-01       Impact factor: 4.200

3.  Carbonated soft drinks alter hepatic cytochrome P450 isoform expression in Wistar rats.

Authors:  Adel Alkhedaide; Mohamed Mohamed Soliman; Zein Shaban Ibrahim
Journal:  Biomed Rep       Date:  2016-09-26

4.  Pharmacokinetic enhancement of inhibitors of the human immunodeficiency virus protease by coadministration with ritonavir.

Authors:  D J Kempf; K C Marsh; G Kumar; A D Rodrigues; J F Denissen; E McDonald; M J Kukulka; A Hsu; G R Granneman; P A Baroldi; E Sun; D Pizzuti; J J Plattner; D W Norbeck; J M Leonard
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

5.  Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes.

Authors:  V A Eagling; J F Tjia; D J Back
Journal:  Br J Clin Pharmacol       Date:  1998-02       Impact factor: 4.335

6.  Gene expression and immunochemical localization of major cytochrome P450 drug-metabolizing enzymes in bovine nasal olfactory and respiratory mucosa.

Authors:  Varsha Dhamankar; Mahfoud Assem; Maureen D Donovan
Journal:  Inhal Toxicol       Date:  2015-11-16       Impact factor: 2.724

7.  Quantitation of pyridyloxobutyl DNA adducts in nasal and oral mucosa of rats treated chronically with enantiomers of N'-nitrosonornicotine.

Authors:  Siyi Zhang; Mingyao Wang; Peter W Villalta; Bruce R Lindgren; Yanbin Lao; Stephen S Hecht
Journal:  Chem Res Toxicol       Date:  2009-05       Impact factor: 3.739

Review 8.  Metabolic activation of clopidogrel: in vitro data provide conflicting evidence for the contributions of CYP2C19 and PON1.

Authors:  Thomas M Polasek; Matthew P Doogue; John O Miners
Journal:  Ther Adv Drug Saf       Date:  2011-12

9.  Protective effect of tea polyphenols against paracetamol-induced hepatotoxicity in mice is significantly correlated with cytochrome P450 suppression.

Authors:  Xia Chen; Chang-Kai Sun; Guo-Zhu Han; Jin-Yong Peng; Ying Li; Yan-Xia Liu; Yuan-Yuan Lv; Ke-Xin Liu; Qin Zhou; Hui-Jun Sun
Journal:  World J Gastroenterol       Date:  2009-04-21       Impact factor: 5.742

10.  Metabolism of propafenone and verapamil by cryopreserved human, rat, mouse and dog hepatocytes: comparison with metabolism in vivo.

Authors:  B Reder-Hilz; M Ullrich; M Ringel; N Hewitt; D Utesch; F Oesch; J G Hengstler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-03-04       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.